ERAS in Posterior Approach of Cervical Spine Operation

October 9, 2022 updated by: Peking University Third Hospital

The Application of Enhanced Recovery After Surgery (ERAS) During the Perioperative Period of Patients With Posterior Approach of Cervical Spine Operation: a Mixed Methods Study

Enhanced recovery after surgery (ERAS) strategy has been used in the patient management of different diseases. This study aims to evaluate the effectiveness of ERAS in the perioperative period of posterior approach of cervical spine operation among patients with CSM.

Study Overview

Status

Completed

Conditions

Detailed Description

Enhanced recovery after surgery (ERAS) strategy has been used in the patient management of different diseases, but up to now, few effort has been done to evaluate the effectiveness of ERAS in patients perioperative management of cervical spine surgery. As a interdisciplinary cooperation system, either qualitative or quantitative method alone can not completely reflect the function of ERAS. Mixed model research (MMR) is a appropriate method to evaluate a complex system, but it has not been used in ERAS evaluation. This study aims to evaluate the effectiveness of ERAS in the perioperative period of posterior approach of cervical spine operation among patients with CSM using MMR, including the retrospective quantitative part and prospective qualitative part. In the retrospective part, we will collect the data of length of stay, VAS scores, mJOA scores and SF-36 scores to compare the difference between ERAS group and regular group. In the prospective part, we will collect the data from the focus group meetings and personal interviews of patients, to verify that ERAS has the ability to improve the postoperative outcomes, while maintain an equal surgical effect.

Study Type

Observational

Enrollment (Actual)

204

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100191
        • Feifei Zhou

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with posterior approach of cervical spine operation

Description

Inclusion Criteria:

  1. Patients should be diagnosed as CSM based on the history, symptoms, Physical signs and radiographic results.
  2. Patients did not respond to the 3-month conventional treatment.
  3. Patients were performed posterior approach of cervical spine operation.
  4. Patients should have complete pre- and post-operative data.

Exclusion Criteria:

  1. Patients with severe organic diseases.
  2. Patients with previous history of cervical spine surgery.
  3. Patients with mental or psychological abnormality.
  4. Patients with severe osteoporosis (T value <-2.5).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Study group
Patients with degenerative CSM or OPLL undergoing C3-7 open-door laminoplasty
ERAS management includes 3 parts: (1) Preoperative analgesia and airway evaluation. (2) The protection and reconstruction of the musculo-ligamentous complex during the surgery, the safe intubation, and the local infiltration anesthesia during surgery. (3) Collar free, multimodal analgesia, airway management, and early recovery after surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Outcomes of pain
Time Frame: Preoperation
Visual analogue scale before after surgery, 0 to 10 points, higher means severer the pain is.
Preoperation
Outcomes of pain
Time Frame: 3 months after surgery.
Visual analogue scale 3-month after surgery, 0 to 10 points, higher means severer the pain is.
3 months after surgery.
Length of stay
Time Frame: Admission to discharge, an average of 3 days
Length of stay
Admission to discharge, an average of 3 days
Neurological function
Time Frame: Preoperation
Modified Japanese Orthopaedic Association score before surgery, -2 to 17 points, higher means better outcome.
Preoperation
Neurological function
Time Frame: 3 months after surgery.
Modified Japanese Orthopaedic Association score 3-month after surgery, -2 to 17 points, higher means better outcome.
3 months after surgery.
Outcomes of quality of life
Time Frame: Preoperation
36-Item Short Form Survey score before surgery, 0 to 100 points, higher means better outcome.
Preoperation
Outcomes of quality of life
Time Frame: 3 months after surgery
36-Item Short Form Survey score 3-month after surgery, 0 to 100 points, higher means better outcome.
3 months after surgery
Focus group meetings
Time Frame: Admission to discharge, an average of 3 days
Focus group meetings by specialists, to discuss the effect of ERAS and the what improvements can be made.
Admission to discharge, an average of 3 days
Personal interviews
Time Frame: At 3-month follow-up
Personal interviews of patients at 3-month follow-up
At 3-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 20, 2019

Primary Completion (ACTUAL)

March 31, 2022

Study Completion (ACTUAL)

March 31, 2022

Study Registration Dates

First Submitted

June 27, 2021

First Submitted That Met QC Criteria

July 4, 2021

First Posted (ACTUAL)

July 14, 2021

Study Record Updates

Last Update Posted (ACTUAL)

October 12, 2022

Last Update Submitted That Met QC Criteria

October 9, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervical Myelopathy

Clinical Trials on Enhanced recovery after surgery

Subscribe